The Graded Redefined Assessment of Strength, Sensation and Prehension is a clinical impairment measure specific to the upper limb for use after tetraplegia
Regular Registration Rates End April 16, 2018! Register Now for the 44th Annual Scientific Meeting in Rochester, MN. (Precourse, May 1, Mayo Clinic) https://t.co/zKSC3RSqap
May 1 -4 2018 the GrasspTest Research and Development Team will present GRASSP Test Version 2 at the annual @ASIA_spine meeting the Mayo Clinic in Rochester, Minnesota. More info at https://t.co/XZBrkH54lL
#SCI
@NeuralOutcomes is a proud sponsor of the #CODESPINE Symposium 2018 taking place at the Toronto Sheraton Airport Hotel and Conference Centre. Take advantage of the group hotel rate ending Feburary 16th! Visit https://t.co/xVg03F7w9s to reserve your spot today
In this inspiring talk “The Man in Motion,” Rick Hansen, discusses how he learned to view his wheelchair as a vehicle for freedom and discusses barriers to success and how to overcome these barriers to liberate society https://t.co/Bmq5R26Chu #accessibility
Did you know that depression is one of the most common conditions secondary to #disability and chronic illness? Today, and every day, let's help reduce the stigma surrounding mental illness. #BellLetsTalk
Scientists have developed a first-of-its-kind, 3-D printed guide that helps regrow both the sensory and motor functions of complex nerves after injury.
https://t.co/3SHq6A58oZ
#spinalcordinjury#paralysis#medicalbreakthrough
#HappyNewYear@NeuralOutcomes is pleased to provide endpoint clinical capacity education and training for pivitol study! #sci#MedEd
https://t.co/MSm1BM0B0K?
The NISCI trial led by Dr Armin Curt is a pinnacle trial which incorporates novel study design elements as well as novel outcomes approaches including GRASSP Version 2. The GRASSP team is eager to begin the trial and are hoping for regulatory approval in Q1 of 2018!
The NISCI Investigators Meeting in Prague!
Dr. Jiri Kris and his team welcomed EMSCI site investigators from Italy, Spain, Germany, Switzerland and the UK this week to finalize the details for the NISCI trial.